D.E. Shaw & Co’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Buy
312,128
+80,381
+35% +$189K ﹤0.01% 3744
2025
Q4
$628K Buy
231,747
+157,592
+213% +$517K ﹤0.01% 3813
2025
Q3
$314K Buy
74,155
+20,235
+38% +$89K ﹤0.01% 4095
2025
Q2
$269K Sell
53,920
-28,371
-34% -$123K ﹤0.01% 3933
2025
Q1
$363K Buy
+82,291
New +$386K ﹤0.01% 3671
2024
Q3
Sell
-90,143
Closed -$703K 4659
2024
Q2
$703K Sell
90,143
-821,075
-90% -$6.08M ﹤0.01% 3409
2024
Q1
$6.47M Buy
911,218
+308,451
+51% +$2.04M 0.01% 1689
2023
Q4
$4.04M Buy
602,767
+122,985
+26% +$693K ﹤0.01% 2083
2023
Q3
$2.7M Sell
479,782
-658,050
-58% -$4.39M ﹤0.01% 2339
2023
Q2
$6.28M Sell
1,137,832
-193,168
-15% -$1.04M 0.01% 1696
2023
Q1
$8.32M Buy
1,331,000
+456,576
+52% +$2.55M 0.01% 1515
2022
Q4
$4.07M Sell
874,424
-76,919
-8% -$379K ﹤0.01% 2288
2022
Q3
$4.44M Sell
951,343
-137,008
-13% -$864K 0.01% 2233
2022
Q2
$6.44M Buy
1,088,351
+1,033,670
+1,890% +$11.5M 0.01% 1821
2022
Q1
$1.06M Buy
54,681
+41,768
+323% +$958K ﹤0.01% 3871
2021
Q4
$422K Buy
+12,913
New +$519K ﹤0.01% 4500
2021
Q3
Sell
-57,423
Closed -$2.08M 5047
2021
Q2
$2.07M Buy
+57,423
New +$2.12M ﹤0.01% 2906

Other funds holding GDRX

D.E. Shaw & Co's GDRX Position: Q1 2026 in Review

D.E. Shaw & Co increased its GoodRx Holdings (GDRX) stake by 35% in Q1 2026, buying an estimated $189K and bringing the position to 312,128 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #3744.

D.E. Shaw & Co first reported a position in GDRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $8.32M in Q1 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • D.E. Shaw & Co held 312,128 shares of GoodRx Holdings worth $612K as of Q1 2026.
  • D.E. Shaw & Co bought 80,381 GoodRx Holdings shares in Q1 2026, an estimated $189K.
  • GoodRx Holdings made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3744 holding.
  • D.E. Shaw & Co first reported a position in GoodRx Holdings in Q2 2021 and has held it in 17 quarters since.
  • D.E. Shaw & Co's GoodRx Holdings position peaked at $8.32M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.